A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. (Q30444953)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56533682)
(Q105531697)
(Q47159504)
(Q91129794)
(Q114338680)
(Q92469404)
(Q92678528)
(Q117248475)
(Q92232353)
(Q117248477)
(P304) 189-193
(P407) (Q1860)
(P433) 2
(P478) 8
(P577) Monday, March 13, 2006
(P921) (Q42824440)
(Q412197)
(Q233309)
(P1433) (Q15724471)
(P1476) "A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study" (language: en)
(P2093) Kathleen Lamborn
W K A Yung
H Ian Robins
Howard A Fine
M Kelly Nicholas
David Schiff
Harry Greenberg
Ken Hess
(P2860) (Q30444760)
(Q35800712)
(Q42597856)
(Q40592020)
(Q35089570)
(Q33342304)
(Q35895167)
(Q48207492)
(Q48821565)
(Q47710641)
(Q73120523)
other details
description scientific article

External Links